Phathom Pharmaceuticals, Inc. (PHAT) vs Replimune Group, Inc. (REPL)
Detailed comparison between Phathom Pharmaceuticals, Inc., Replimune Group, Inc..Total Return (%)
Phathom Pharmaceuticals, Inc. (PHAT)Replimune Group, Inc. (REPL)
Which stock do you think will perform better?
Phathom Pharmaceuticals, Inc.
PHAT
Replimune Group, Inc.
REPL
| Metric | Phathom Pharmaceuticals, Inc. (PHAT) | Replimune Group, Inc. (REPL) |
|---|---|---|
| Current Price | $14.32 | $8.98 |
| Change | -0.04 (-0.28%) | -0.03 (-0.33%) |
| Market Cap | $1.02B | $0.70B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -3.58 | -3.34 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $16.08 | $17.00 |
| 52-Week Low | $2.21 | $2.68 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.76 | $-3.47 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| PHAT | 6.39% | 104.86% | 53.32% | -66.70% | -41.79% | -41.79% |
| REPL | 8.19% | -31.03% | -39.85% | -81.62% | -40.77% | -40.77% |